Prevalence Of Metabolic Syndrome In VA Patients With Second …
Effects and Tardive Dyskinesia Atypical Antipsychotic Agents Clozapine (Clozaril®) Risperidone (Risperdal®) Olanzapine (Zyprexa®) Quetiapine (Seroquel®) Ziprasidone (Geodon®) Aripiprazole (Abilify®) Short-Term Studies: Weight Gain Long-Term Studies: Weight Gain Clozapine-treated patients … Fetch This Document
Antipsychotic Agents And Diabetes
Clozapine and olanzapine had more weight gain and metabolic side effects then quetiapine and risperidone. Patients treated with olanzapine gained an average of 2 pounds per month, and a Olanzapine (Zyprexa) – 1996 Quetiapine (Seroquel) – 1997 Ziprasidone (Geodon) – 2001 Aripiprazole (Abilify … Read Content
Atypical Antipsychotics
More evidence, generic Abilify Less weight gain & dyslipidemia More activating than sedating (start low & go slow) Require close monitoring of therapeutic effects & side effects Patients may need polytherapy … Fetch Here
12 CLINICAL PHARMACOLOGY
Due to weight gain occurred in 1% of olanzapine-treated patients, compared to 0% of placebo-treated patients. Table 7: Weight Gain with Olanzapine Use in Adolescents from 4 Placebo-Controlled Trials … Read Document
New Medication Approved For Schizophrenia LATUDA
(PEARL 1-2-3) trial results, weight gain among patients on Latuda was “markedly lower” than that of patients taking olanzapine. “Weight gain results with Latuda are right there with … Fetch Content
Dof Major Depressive Disorder (MDD), 30% To 46%
The same 2 patients reported restlessness on spontaneous reports of adverse events. Pa-tients did not significantly gain or lose weight during the (Abilify), bupropion (Wellbutrin and others), carbamazepine (Carbatrol, Equetro, and others … View Document
WARNINGS AND PRECAUTIONS —– HIGHLIGHTS OF …
weight gain was 0.43 kg for LATUDA-treated patients compared to -0.02 kg for placebo-treated patients. Change in weight from baseline for olanzapine was 4.15 kg and for quetiapine … Fetch Doc
Aripiprazole, A “Dopamine-Serotonin System Stabilizer” In …
Clinically significant weight gain occurred less frequently with aripiprazole than with olanzapine. healthy subjects (US Prescribing Information AbilifyTM). Contraindications Aripiprazole is contraindicated in patients with a known … Content Retrieval
Elevated Lipase And Diabetic Ketoacidosis Associated With …
(Abilify®) was initiated 18 months ago prior to admission. Since that time, the patient had gain and it would be prudent to constantly monitor patients weight and blood sugars as … Read More
HIGHLIGHTS OF PRESCRIBING INFORMATION Hyperglycemia And …
Patients should be advised that they may experience weight gain. Patients should have their weight monitored regularly [see Warnings and Precautions (5.6)]. … Read More
Aripiprazole – A New Class Of Antipsychotic
Aripiprazole (Abilify) is the latest antipsychotic to be registered in excessive weight gain or cardiac rhythm disturbance, nor is it associated with It would be useful for patients in whom potential side effects such as significant weight gain and … Read Full Source
Psychtropic Drug Therapy
FDA Warning (2004) Patients on certain antidepressants should be closely monitored for warning aripiprazole (Abilify) Weight gain, minimal EPS, minimal elevation of prolactin level … Retrieve Content
MEDICATION GUIDE ABILIFY Generic Name: Aripiprazole
Increased risk of death in elderly patients with dementia-related psychosis: Medicines like ABILIFY can raise the risk of death in elderly people who have lost • fatigue • weight gain • increased appetite • uncontrolled movement such as … Access Content
SwitchingtoAripiprazoleasaStrategyforWeightReduction: AMeta …
Using aripiprazole to determine weight change in adult patients. The search terms were (“aripiprazole” or “abilify”), patients gain weight when treatment with an antipsychotic is switched to aripiprazole. … View This Document
PURLs
And for patients who gain 5% or more of their initial weight or develop worsening aripiprazole (abilify) +/– – tABLE 1 CoNtINuED … Access Document
Antipsychotic Drugs Anti Mania Drugs
(Abilify) cause weight gain Result in poor self-esteem and noncompliance Additional Notes cont: For patients who tend to cheek their meds many of the major antipsychotics and … Fetch Here
PHARMACY BENEFIT UPDATE Spring 2009 Issue
Abilify is currently a non-preferred atypical antipsychotic under the Mainecare PDL. order to identify early on weight gain and metabolic worsening that serve to put our patients in harms way. … Fetch Document